PA5-42206

antibody from Invitrogen Antibodies

Targeting: HPR

Western blot (Supportive data in Antibodypedia)

Other assay (Supportive data in Antibodypedia)

Antibody Data

Product number

PA5-42206

Provider

Invitrogen Antibodies

Product name

HPR Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Synthetic peptide

Description

Peptide sequence: CLPSKNYAEV GRVGYVSGWG QSDNFKLTDH LKYVMLPVAD QYDCITHYEG Sequence homology: Human: 100%

Reactivity

Human

Host

Rabbit

Isotype

IgG

Vial size

100 µL

Concentration

0.5 mg/mL

Storage

-20° C, Avoid Freeze/Thaw Cycles

References

Submitted references

Exosome Proteomics Reveals the Deregulation of Coagulation, Complement and Lipid Metabolism Proteins in Gestational Diabetes Mellitus.

Bernea EG, Suica VI, Uyy E, Cerveanu-Hogas A, Boteanu RM, Ivan L, Ceausu I, Mihai DA, Ionescu-Tîrgoviște C, Antohe F
Molecules (Basel, Switzerland) 2022 Aug 26;27(17)

Western blot

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Western blot analysis of human thymus tumor cell lysate using an anti-HPR polyclonal antibody (Product # PA5-42206).

Other assay

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Validation by Western blotting of some protein markers identified by mass spectrometry: ( a ). Alpha-1-B Glycoprotein (A1BG) and ( b ). Haptoglobin-related protein (HPR). Representative immunoblots and densitometric analysis for each protein are shown. Ponceau S staining was used for normalization of the proteins' levels. Western blot analysis of serum exosome lysates demonstrated protein level alterations in A1BG and HPR in the GDM vs. CG comparison. Statistical analysis was performed using unpaired Student's t test, and the results were expressed as means +- standard deviation (SD); * p < 0.05. CG: control group ( n = 6) and GDM: gestational diabetes group ( n = 6).